REG - Lloyds Bank Plc - PUBLICATION OF PRICING SUPPLEMENT

Lloyds BankingAnnouncement

31/08/2023 12:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230831:nRSe9800Ka&default-theme=true

RNS Number : 9800K  Lloyds Bank PLC  31 August 2023

NOTICE

 

Publication of PRICING SUPPLEMENT

 

 

LLOYDS BANK PLC

(the Issuer)

 

Publication of PRICING SUPPLEMENT

The following Pricing Supplement under the €60 billion Global Covered Bond
Programme of Lloyds Bank plc are available for viewing:

CHF 440,000,000 1.870 per cent. Series 2023-3 Fixed Rate Covered Bonds due
August 2027

To view the Pricing Supplement, please paste the following URL into the
address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/9800K_1-2023-8-31.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/9800K_1-2023-8-31.pdf)

The Pricing Supplement has been submitted to the National Storage Mechanism
and will shortly be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

For further information, please contact:

Investor Relations:

 

Douglas Radcliffe

Group Investor Relations Director

Tel:      +44 (0) 20 7356 1571

E-mail: douglas.radcliffe@lloydsbanking.com
(mailto:douglas.radcliffe@lloydsbanking.com)

 

Corporate Affairs:

 

Matt Smith

Head of Media Relations

Tel:       +44 (0) 20 7356 3522

E-mail:   matt.smith@lloydsbanking.com (mailto:matt.smith@lloydsbanking.com)

 

Debt Investor Relations:

 

Pascale Dorey

Debt Investor Relations

Tel:        +44 (0) 20 7354 7402

E-mail: pascale.dorey@lloydsbanking.com

Lloyds Bank plc

Registered Office

25 Gresham Street

London EC2V 7HN

Disclaimer - Intended Addressees

Please note that the information contained in this announcement and the
Pricing Supplement may be addressed to and/or targeted at persons who are
residents of particular countries (specified in the Base Prospectus) only and
is not intended for use and should not be relied upon by any person outside
these countries and/or to whom this announcement and Pricing Supplement are
not addressed.  Prior to relying on the information contained in this
announcement and the Pricing Supplement, you must ascertain from the Base
Prospectus whether or not you are one of the intended addressees of the
information contained in this announcement and the Pricing Supplement.

In particular, this announcement and the Pricing Supplement do not constitute
an offer or invitation to subscribe for, or purchase, securities in the United
States or in any other jurisdiction where such an offer or invitation would be
unlawful.  This announcement and the Pricing Supplement are not for
distribution in the United States or to U.S. persons (as defined below).  The
securities described herein have not been, and will not be, registered under
the U.S. Securities Act of 1933, as amended (the Securities Act) or under any
relevant securities laws of any state of the United States of America and are
subject to U.S. tax law requirements.  The securities may not be offered or
sold within the United States or to, or for the account or benefit of, U.S.
persons or to persons within the United States of America (as such terms are
defined in Regulation S under the Securities Act) except pursuant to
registration or an exemption from the registration requirements of the
Securities Act.  There will be no public offering of the securities in the
United States. For a description of the restrictions on offers and sales of
the securities described herein, please refer to the Supplementary Prospectus
and Base Prospectus.

Your right to access this service is conditional upon complying with the above
requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PSPWPUUPRUPWGUG